维普期刊资源整合服务平台（V6.5）

47篇 您的检索式：作者名="AMBINDER R"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial 显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，：	1
2	Gemcitabine as first line therapy in patients with metastatic breast cancer a phase Ⅱ trial显示文摘	Blackstein M Vogel C L Ambinder R	2002	Oncology2002，62，1：	1
3	Gemeitabine as first line therapy in patients with metastaticbreast cancer:a phase Ⅱ trial显示文摘	Blackstein M Vogel C L Ambinder R	2002	Oncology2002，62，1：	1
4	Gemcitabine as first-line therapy in patients with metastatic breast cancer: a Phase Ⅱ trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，52，1：	1
5	Gemeitabine as firest-line therapy in patient with metastatic breast cancer: aphase Ⅱ trial显示文摘	Blaekstein M Vogel C L Ambinder R	2002	Oncology2002，62，：	1
6	Gemcitabine as first -line therapy in patients with metastatic breast cancer ;a phase Ⅱ trial显示文摘	VOGEL C L AMBINDER R	2002	Oncology2002，62，1：	1
7	Gemcitabine as firsfline thempy in patients with metastatic breast cancer:a phase Ⅱ trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
8	Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase Ⅱ trial 显示文摘	Blaekstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
9	Gemcitabine as firstline therapy in patients with metastatic breast cancer: aphase II trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
10	Gemcetabine as first-line therapy in patients with metastatic breast cancer:a phase Ⅱ trail显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
11	Gemcitabine as first line therapy in patientwith metastatic breast cancer: a phase Ⅱ trial 显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，：	1
12	Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase Ⅱ trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
13	Gemcitabine as first line therapy in patient with metastatic breast cancer,a phase Ⅱ trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
14	Gemcitabin as firstline therapy in patients with metastatic breast cancer: a phase Ⅱ trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，52，1：	1
15	Gemcitabine as firs-line therapy in patinets with metastatic breast cancer a phas II trail 显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
16	Gemcitabin as first-line therapy in patients with metastatic breast cancer:a phase Ⅱ trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，52，1：	1
17	查看详情显示文摘	Macmahon E M E Ambinder R F		0，，：	1
18	Gemcitabine as first-line therapy in patients with metastatic breast can- cer:a phase II trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
19	Gemcitabine as first line therapy in patient with metastatic breast cancer: a phase Ⅱ trial 显示文摘	Blackstein M Vogel C L Ambinder R	2002	Oncology2002，62，1：	1
20	Gemcitabine as first-line therapy in patinets with metastatic breast cancer a phase Ⅱ trail显示文摘	Vogel CL Ambinder R	2002	Oncology2002，62，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示